Human PGK (ϳ46 kDa) is a glycolytic enzyme that catalyzes the conversion of 1,3-biphosphoglycerate to 3-phosphoglycerate and during the process generates one molecule of ATP (17). The reaction is reversible. In addition to its participation in the glycolytic cycle, cytoplasmic PGK is known to stimulate viral mRNA synthesis (18). It is also expressed in the nuclei where it modulates DNA synthesis and repair (19 -21). Since PGK in nuclei retains its ability to bind to its natural substrates, it has been proposed that its activity in nuclei may be regulated by the energy state of the cell (21). Extracellular PGK was recently shown to have a thiol-reductase activity (22). Reduction of plasmin by PGK results in proteolysis of plasmin to angiostatin fragments, which are inhibitors of angiogenesis (23-25). ATP and 3-phosphoglycerate could inhibit reduction of plasmin, presumably through inducing a conformational change that was not favorable to the reduction of plasmin (25). This suggested that the level of nucleoside diphosphates or triphosphates (natural or otherwise) might have a regulatory impact on the multiple cellular functions of PGK.The sequences of mammalian PGKs are conserved over 96%, and there is also a high level of tertiary structure homology (26). The crystal structures of horse muscle PGK in